KVUE: Kenvue Corp Company Value to Net Income

Corporate emblem and logo of Kenvue Inc (KVUE)

Kenvue Inc. (KVUE) demonstrates stability driven by an ethical corporate culture and strong brands. The company's P/E ratio confirms market confidence in its assets, where 22.10 characterizes this valuation parameter. Business efficiency is supported by the optimization of wholesale retail deliveries and the large-scale implementation of warehouse robotics with AI planning, which minimizes costs and guarantees an uninterrupted distribution of products.

KVUE Kenvue Health: Price to Earnings Ratio in the range 02/21/2024 - 11/13/2026

Comprehensive metric breakdowns and analytics for Kenvue Corp (KVUE)

- price and consensus price forecast:
Stock Price kenvue.com|KVUE - Consensus Target
- market capitalization information:
Market Value Kenvue Inc.|KVUE - Total Company Value
- balance sheet net asset value indicators:
Net Asset Value per Share Kenvue|KVUE - Company Net Assets|Market Cap to Book Value Multiple kenvue.com|KVUE - Company Total Assets
- company liabilities and liquidity data:
All Debt to Shareholders' Equity Ratio Kenvue Inc.|KVUE - Long-Term Debt to Capital|Current Liabilities to Capital Kenvue Health|KVUE - Company Debts|Debt to Net Assets Ratio Kenvue Inc.|KVUE - Company Long-Term Debt|Company Short-Term Debts Kenvue|Immediate Liquidity kenvue.com
- business earnings and investment ratios data:
KVUE - Company Net Income|Net Profit Forecast Kenvue Inc.|KVUE - Price to Earnings Ratio|Future Price to Earnings Kenvue Inc|KVUE - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Kenvue Inc.|KVUE - Operating profit EBITDA|Net earnings per one share for the last twelve months Kenvue|KVUE - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months kenvue.com|KVUE - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Kenvue Inc.
Comprehensive company analysis:kenvue.com - KVUE
Flagship merchandise of Kenvue

The resilience of Kenvue Inc. (KVUE), driven by stringent drug certification and economies of scale, creates a foundation for stable cash flows. By analyzing the issuer's P/E history, an investor can see the ratio of current market capitalization to actual net income from previous periods. This metric measures the investment payback period, revealing the balance between accounting reliability and growth expectations. Such characteristics define the security's status as a defensive asset.

Analysis of competing companies

P/E Multiple haleon.com|Price to Earnings Ratio VRNA (Verona Pharma)|MENS (Jyong Biotech Limited) - Company Value to Net Income|Price to Earnings Ratio Ligand Pharma LGND|Amneal Corp (AMRX) - Market Cap to Earnings|PRGO: Price to Earnings Ratio|alvotech.com - Market Price to Net Income Ratio|LQDA: P/E Multiple|Galapagos N.V. - Company Value to Net Income|ANIP (ANI Pharma) - P/E Multiple|Market Cap to Earnings Afrezza MNKD|Price to Earnings Ratio Amphastar Pharmaceuticals (AMPH)|PCRX (pacira.com) - Company Value to Net Income|Price to Earnings Ratio ARS Pharmaceuticals, Inc. SPRY|P/E Multiple Theravance Biopharma Inc TBPH|Aquestive Pharma - P/E Multiple|Market Cap to Earnings scPharmaceuticals Inc.|tectonictx.com (TECX) - Price to Earnings Ratio|Price to Earnings Multiple TNXP|Price to Earnings Ratio SXTC|Price to Earnings Ratio EPRX|Price to Earnings Ratio BHST (BioHarvest)|P/E Multiple Invizyne (EXOZ)|P/E Multiple ORMP (Oramed Pharmaceuticals Inc.)|Entera Bio Ltd (ENTX) - Market Cap to Earnings|HYFT: Price to Earnings Ratio|Company Value to Net Income ABVC (ABVC BioPharma Inc.)|CPIX: P/E Multiple|QNTM - Business Payback Period|Price to Earnings Ratio FibroGen, Inc.|Price to Earnings Multiple TELO (telomirpharma.com)|P/E Multiple RANI|Price to Earnings Ratio synergychc.com SNYR|Rallybio - Price to Earnings Ratio|Business Payback Period Lexaria Bioscience Corp (LEXX)|PULM - Price to Earnings Ratio|PTHL - P/E Multiple|APM (aptorumgroup.com) - Price to Earnings Ratio|LYRA (Lyra Therapeutics Inc.) - Price to Earnings Ratio|Price to Earnings Ratio IBO|P/E Multiple TNF Pharma|P/E Multiple YCBD|PRFX - Market Cap to Earnings|Price to Earnings Ratio Altamira Therapeutics Ltd. CYTO|LIPO (Lipella Pharmaceuticals Inc) - Market Cap to Net Income|Optinose - P/E Multiple|Company Value to Net Income PIRS (Pieris Pharma)|PROC: P/E Multiple|petrospharma.com (PTPI) - P/E Multiple|Price to Earnings Ratio Qilian International Holding|SLRN: Company Value to Net Income|Price to Earnings Ratio TFF Pharma (TFFP)